Form S-3 Tvardi Therapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Tvardi Therapeutics (TVRD) files $200M mixed shelf
May 1, 2026 4:08 PM EDTTvardi Therapeutics (NASDAQ: TVRD) has filed $200,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
